Herceptin 150 mg/7.4mL
Trastuzumab · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Genentech, Inc.
No Recall History
Plain English
Herceptin is a injection, powder, lyophilized, for solution containing trastuzumab at 150 mg/7.4mL, taken intravenous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Herceptin
- Generic Name
- Trastuzumab
- NDC Code (Product)
50242-132- Manufacturer
- Genentech, Inc.
- Strength
- 150 mg/7.4mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA103792
- Drug Class
- HER2/neu Receptor Antagonist [EPC]
- Marketing Start
- 02/10/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Herceptin used for?
Herceptin contains Trastuzumab. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Herceptin a controlled substance?
Herceptin is not classified as a controlled substance by the DEA.
What is the generic name for Herceptin?
The generic name for Herceptin is Trastuzumab. There are 12 other brand versions of Trastuzumab.
What is the NDC code for Herceptin 150 mg/7.4mL?
The NDC (National Drug Code) for Herceptin 150 mg/7.4mL is 50242-132, listed by Genentech, Inc..